Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Molecular Medicine2002Vol. 8(8), pp. 495–505
Citations Over TimeTop 1% of 2002 papers
Hannelore Ehrenreich, Martin Hasselblatt, Christoph Dembowski, Lukas Cepek, Piotr Lewczuk, Michael Stiefel, Hans-Heino Rustenbeck, N Breiter, Sonja Jacob, Friederike Knerlich‐Lukoschus, Matthias Bohn, W. Poser, Eckart Rüther, Michael M. Kochen, Olaf Gefeller, Christoph H. Gleiter, Thomas Wessel, Marc De Ryck, Loretta M. Itri, Hilmar Prange, Anthony Cerami, Michael Brines, Anna‐Leena Sirén
Abstract
Intravenous high-dose rhEPO is well tolerated in acute ischemic stroke and associated with an improvement in clinical outcome at 1 month. A larger scale clinical trial is warranted.
Related Papers
- Application of Fluid-Attenuated Inversion-Recovery(FLAIR) Sequence in Low Field MR of Cerebral Infarction(2004)
- Application of fluid-attenuated inversion-recovery (FLAIR) sequences in low field strength MRI of the brain(2005)
- MRI of the brain using FLARI and turboSE(1999)
- Application of Fluid-attenuated Inversion Recovery(FLAIR) Sequence in Cerebral tumor Using Low Field Strength MR(2006)